Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has provided an update.
PharmaCorp Rx Inc. has announced the granting of 827,603 stock options to its directors, officers, employees, and consultants, with an exercise price of $0.48 and an expiry date of July 1, 2035. This move, subject to TSX Venture Exchange approval, utilizes exemptions from formal valuation and minority approval requirements, as the options’ fair market value does not exceed 25% of the company’s market capitalization. This strategic decision could potentially enhance stakeholder alignment and incentivize key personnel, thereby impacting the company’s operational dynamics and market positioning.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates three PharmaChoice bannered pharmacies in Canada and plans to expand by acquiring more PharmaChoice Canada branded pharmacies as well as independently owned non-PharmaChoice Canada bannered pharmacies. These acquisitions will be integrated under the PharmaChoice Canada banner. The company’s shares are traded on the TSX Venture Exchange under the symbol PCRX.
Average Trading Volume: 23,522
Technical Sentiment Signal: Buy
Current Market Cap: C$46.7M
Find detailed analytics on PCRX stock on TipRanks’ Stock Analysis page.